23 May 2013
Keywords: 500mcg, betaferon, fails, show, result, rrms, bayer
Article | 05 November 2007
Bayer Schering Pharma AG says that top-line results from the BEYOND study, a large randomized trial of patients with relapsing-remitting
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 October 2007
5 November 2007
© 2013 thepharmaletter.com